|
|
Lupin’s manufacturing facilities, spread across India,
play a critical role in enabling the Company realize its
global aspirations, benchmarked to International
standards, these facilities are approved by
international regulatory agencies like US FDA, UK MHRA,
TGA Australia, WHO, and MCC South Africa. The Company
has leveraged its strong vertical integration in
building a global pharmaceutical powerhouse.
 |
|
Key Products: APIs and Intermediates
Approved by:
WHO (Geneva)
|
|
Ankleshwar, Gujarat, India |
|
Top |
| |
|
|
|
| |
|
|
 |
|
Key Products: APIs and
Intermediates
Approved by:US FDA
WHO
|
|
Tarapur, Maharashtra, India |
|
Top |
| |
|
|
|
| |
|
|
 |
|
Key Products: APIs and Formulations
Approved by:
WHO
US FDA
UK MHRA |
|
|
|
Mandideep, Madhya Pradesh, India |
|
Top |
| |
|
|
|
| |
|
|
 |
|
Key Products: Formulations
Approved by:
WHO (Geneva)
|
|
Aurangabad, Maharashtra, India |
|
Top |
| |
|
|
|
| |
|
|
 |
|
Key Products: Formulations
Approved by:US FDA
UK MHRA
|
| |
|
| |
|
|
Goa, India |
|
Top |
|
|
|
|
|
|
|
|
|
 |
|
Key Products: Formulations
|
|
|
| |
|
| |
|
| |
|
| |
|
|
Jammu, Jammu & Kashmir, India |
|
Top |
|
|
|
|
|
|
|
|
|
 |
|
Key Products: Formulations
Approved by:
(In the pipeline)
|
| |
|
| |
|
| |
|
|
Indore, Madhya Pradesh, India |
|
Top |
|
|
|
|
|
|
|
|
|
 |
|
Key Products: Formulations
Approved by:
MOH (Japan)
|
|
|
|
|
|
Kyowa, Japan |
|
Top |
|
|
|
